Pathway Rx
LMIA employer · Calgary, Alberta
- Province or territory
- Alberta
- City
- Calgary
- Positions on positive LMIAs
- 1
- Periods listed
- 1
- First and latest list
- 2023 Q3 · 2023 Q3
LM<CANPATHWAY<RX<<<<<<<<<<<<<<<<<<<<<<<<<<<< AB3<P18<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<8
Positive LMIAs
Each row is one line of an ESDC quarterly or annual list: approved positions for a stream, occupation and work location.
- Approved positions
- 1
- Year
- 2023
| Period | Stream | Occupation (NOC) | Work location | LMIAs | Positions |
|---|---|---|---|---|---|
| 2023 Q3 | High-wage stream (TFWP) | 21110 Biologists and related scientists | Calgary | 1 | 1 |
Occupations
Approved positions by NOC 2021 unit group (older lists mapped from NOC 2011 with the Statistics Canada concordance).
- Main occupation
- 21110 Biologists and related scientists
- Its share of this employer's positions
- 100.0%
- Streams used
- High-wage stream (TFWP)
Wages for Biologists and related scientists
Prevailing wages for this employer's main occupation (NOC 21110).
- Median wage, Alberta
- C$41.44 per hour
- Median wage, Canada
- C$40.00 per hour
- Job Bank postings in Alberta, Jan–Sep 2026
- 19
- Median advertised minimum hourly wage
- C$41.36
Employers in Calgary
Other employers with positive LMIAs at the same location.
- LMIA employers in Calgary
- 9,710
- Positions on positive LMIAs in Calgary
- 41,373
- This employer's share
- 0.00%
Among LMIA employers
Pathway Rx has 1 positions on positive LMIAs, ranking #93,577 of 151,287 LMIA employers in Canada and #19,127 of 29,436 in Alberta. Its main occupation, Biologists and related scientists, accounts for 206 approved positions nationally; this employer holds 0.49% of them.
- Rank in Canada by positions
- 93,577 of 151,287
- Rank in Alberta
- 19,127 of 29,436
- Positions nationally, NOC 21110
- 206
- This employer's share
- 0.49%
Official data, not advice. Visa Atlas publishes figures from government registers and statistics. It does not assess eligibility or give immigration advice; for advice, consult a regulated adviser. Read more